Nasal Iodophor vs Nasal Mupirocin With Chlorhexidine Baths to Prevent Infections in Adult ICUs
Nasal mupirocin plus chlorhexidine baths in ICUs prevents methicillin-resistant Staphylococcus aureus (MRSA) infections but raises concern about antibiotic resistance. JAMA Senior Editor Kristin Walter, MD, speaks with Susan Huang, MD, of University of California, Irvine, about a study comparing iodophor vs mupirocin with chlorhexidine bathing for ICU-attributable S aureus clinical cultures. Related Content: Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - October 10, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
SCCM Pod-420 Nebulized Bacteriophages for Prophylaxis of Experimental MRSA VAP
Alternative strategies are needed to combat and prevent antibiotic-resistant bacterial infections. Host Ashish K. Khanna, MD, FCCP, FCCM, talks with David R. Cameron, PhD, about the potential for bacteriophage prophylaxis in the context of experimental ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus in rats. (Source: SCCM PodCast - iCritical Care)
Source: SCCM PodCast - iCritical Care - September 10, 2020 Category: Intensive Care Authors: The Society of Critical Care Medicine (SCCM) Tags: Medicine Source Type: podcasts
Incisional Negative Pressure Wound Therapy for SSI Prevention, MRSA Bacteremia and Combination Therapy, Review of Parkinson Disease, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 11, 2020 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - February 11, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Nature PastCast, August 1975: Antibodies ’ ascendency to blockbuster drug status
This year, Nature celebrates its 150th birthday. To mark this anniversary we’re rebroadcasting episodes from our PastCast series, highlighting key moments in the history of science.They’re found in home-testing kits for pregnancy, hospital tests for MRSA, and in six out of ten of the best-selling drugs today. But monoclonal antibodies have kept a surprisingly low profile since their debut in a Nature paper in 1975. This podcast follows them from that time through patent wars, promising drug trials and finally to blockbuster status today.This episode was first broadcast in August 2013.From the archive:Continuous culture...
Source: Nature Podcast - August 30, 2019 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Nature PastCast, August 1975: Antibodies ’ ascendency to blockbuster drug status
This year, Nature celebrates its 150th birthday. To mark this anniversary we’re rebroadcasting episodes from our PastCast series, highlighting key moments in the history of science.They’re found in home-testing kits for pregnancy, hospital tests for MRSA, and in six out of ten of the best-selling drugs today. But monoclonal antibodies have kept a surprisingly low profile since their debut in a Nature paper in 1975. This podcast follows them from that time through patent wars, promising drug trials and finally to blockbuster status today.This episode was first broadcast in August 2013.From the archive:Continuous culture...
Source: Nature Podcast - August 30, 2019 Category: Science Authors: Springer Nature Limited Source Type: podcasts
"Mudicinal Properties" -- The Discovery Files
Arizona State University and Mayo Clinic researchers have found that one type of clay, Oregon blue clay, may help fight disease-causing bacteria in wounds, including treatment-resistant bacteria. In laboratory tests, the researchers found that the clay has antibacterial effects against bacteria such as Escherichia coli and Staphylococcus aureus, including strains such as carbapenem-resistant Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA). (Source: The Discovery Files)
Source: The Discovery Files - September 6, 2018 Category: Science Authors: National Science Foundation Source Type: podcasts
Influenza and MRSA Pneumonia
Dr Paul Auwaerter discusses the antimicrobial options for postinfluenza MRSA pneumonia, and makes the case for a universal flu vaccine. (Source: Medscape Infectious Disease Podcast)
Source: Medscape Infectious Disease Podcast - March 5, 2018 Category: Infectious Diseases Authors: Medscape Source Type: podcasts
Infections: Methicillin-Resistant Staphylococcus Aureus (MRSA)
Dr. Sandra Fowler, a pediatric infectious diseases specialist, discusses the Methicillin-resistant Staphylococcus aureus (MRSA) infection, describing the mechanism by which the community-acquired strain may have flourished in recent years. She explains symptomology and treatment of this strain, noting the low fatality rate as compared to the hospital-associated strain of MRSA. Dr. Fowler also offers precautionary measures against development of MRSA, pointing to the importance of good hand hygiene. (Source: MUSC Dermatology Podcast)
Source: MUSC Dermatology Podcast - April 5, 2014 Category: Dermatology Authors: Medical Univeristy of South Carolina Source Type: podcasts
Who, when and how: Screening for MRSA
Meticillin resistant Staphylococcus aureus (MRSA) remains one of the foremost hospital acquired pathogens.
Patients colonised or infected with MRSA provide a reservoir within hospitals, although infection prevention and control measures minimise the risk of transmission.
Although there is broad agreement on the control measures required for... (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 21, 2014 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Who, when and how: Screening for MRSA
Meticillin resistant Staphylococcus aureus (MRSA) remains one of the foremost hospital acquired pathogens.
Patients colonised or infected with MRSA provide a reservoir within hospitals, although infection prevention and control measures minimise the risk of transmission.
Although there is broad agreement on the control measures required for patients colonised or infected with MRSA, there is considerable controversy over who, when and how to screen for the bacteria.
John Coia, a consultant microbiologist at Glasgow Royal Infirmary, discusses when screening may be appropriate, how it should be carried out, and the best st...
Source: The BMJ Podcast - March 21, 2014 Category: General Medicine Authors: BMJ Group Source Type: podcasts
" Toxic Sop " -- The Discovery Files
Researchers at UC San Diego have created nanosponges that soak up a dangerous pore-forming toxin produced by MRSA could serve as a safe and effective vaccine against this toxin. (Source: The Discovery Files)
Source: The Discovery Files - January 7, 2014 Category: Science Authors: National Science Foundation Source Type: podcasts
Universal precautions and MRSA/VRE acquisition in the ICU, diabetes' patients QOL after CABG vs PCI, management of asymptomatic carotid artery stenosis, and more.
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 16, 2013 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - October 15, 2013 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
